No significant difference in cardiovascular risk between males and females.No detectable risk from nonstimulant medication use.Moreover, there was no increased risk of cardiovascular disease, regardless of the type of CVD the patient had when starting the ADHD stimulant, or that developed while they were taking ADHD medications.
These include:Stroke, cerebrovascular disease, or hemorrhageNow that we know fears over an elevated risk of medication complications were unfounded, clinicians who either refused to consider prescribing stimulant medications or who, more commonly, discontinued prescribing the first-line stimulant medications when their patients reached older ages, can move forward by providing necessary and appropriate treatment.research.